All Research Peptides

GLP-1 S 5mg

Synthetic GLP-1 receptor agonist with C18 fatty diacid modification for extended half-life (~7 days). 5mg vial — entry-level supply for GLP-1 receptor pharmacology, appetite regulation, and incretin signaling research. >98% purity, HPLC verified, lyophilized.

CAS: 910463-68-2

GLP-1 S 10mg

GLP-1 S (Semaglutide) 10mg — the most popular research vial size. Sufficient for extended GLP-1 receptor agonism studies at standard research concentrations. Lyophilized powder, >98% purity. Requires BAC water for reconstitution.

CAS: 910463-68-2

GLP-1 S 15mg

GLP-1 S (Semaglutide) 15mg — best-value single vial for long-duration GLP-1 research protocols. 50% more material than the 10mg at a proportionally lower price per mg. Lyophilized, >98% purity, HPLC tested.

CAS: 910463-68-2

GLP-2 T 15mg

Tirzepatide (GLP-2 T) is a dual GLP-1/GIP receptor agonist — activating both incretin receptors simultaneously for additive effects on insulin secretion and energy intake reduction. Research shows significantly greater weight reduction in obese models vs. GLP-1 monotherapy. Frequently compared head-to-head with semaglutide in mechanistic studies. 15mg lyophilized, >98% purity.

CAS: 2023788-19-2

GLP-2 T 30mg

Tirzepatide (GLP-2 T) 30mg — double supply for extended dual GLP-1/GIP research. Best option for longitudinal studies comparing tirzepatide and semaglutide mechanisms side-by-side in the same protocol. Lyophilized, >98% purity.

CAS: 2023788-19-2

GLP-2 T 60mg

Tirzepatide (GLP-2 T) 60mg — bulk supply for high-throughput or multi-cohort GLP-1/GIP research. Lowest price per mg. Ideal for labs running parallel semaglutide vs. tirzepatide comparison studies requiring large, consistent quantities.

CAS: 2023788-19-2

GLP-1 C + GLP-1 S

Combination vial of GLP-1 C (Cagrilintide — long-acting amylin analog) and GLP-1 S (Semaglutide). Mirrors the CagriSema combination studied in Novo Nordisk's REDEFINE trials, which showed greater weight reduction than semaglutide monotherapy. Research applications include dual amylin/GLP-1 mechanism studies and satiety pathway investigation.

CJC-1295 / Ipamorelin (No DAC)

Combination of CJC-1295 (GHRH analog, No DAC) and Ipamorelin (selective GHRP). Researched alongside GLP-1 agonists in body composition studies — GLP-1s reduce energy intake while GH secretagogues support lean mass preservation during caloric deficit. CJC-1295 stimulates pulsatile GH release; Ipamorelin provides selectivity without cortisol or prolactin elevation.

BPC-157 10mg

BPC-157 is a 15-amino acid gastric peptide studied for gut lining integrity, NO system modulation, and anti-inflammatory effects. Relevant in GLP-1 research — GLP-1 agonists delay gastric emptying and alter GI motility; BPC-157 research models investigate protective effects on the GI tract during incretin agonist protocols. Lyophilized, >98% purity.

CAS: 137525-51-0

NAD+ 500mg

NAD+ is a critical coenzyme in cellular energy metabolism and a substrate for sirtuins (SIRT1-7) and PARPs. NAD+ intersects with GLP-1 biology at the pancreatic beta cell level — NAD+ supports beta cell survival and insulin secretion, while GLP-1 receptor agonism amplifies glucose-stimulated insulin release. Combined NAD+/GLP-1 protocols model dual-pathway metabolic restoration.

CAS: 53-84-9

Bacteriostatic Water Reconstitution Solution 10ml

0.9% benzyl alcohol bacteriostatic water for peptide reconstitution. Required for all lyophilized GLP-1 research peptides — Semaglutide, Tirzepatide, Retatrutide, CJC-1295/Ipamorelin, and BPC-157. 10ml multi-use vial; benzyl alcohol preservative allows multi-draw use over 28 days.

GHK-CU 50mg

GHK-CU (copper peptide) 50mg research compound. Key component of Clavicular's GLOW protocol — studied for collagen synthesis, skin regeneration, angiogenesis, and anti-aging effects in preclinical models. The 'GLOW peptide' of the Clav stack.

CAS: 49557-75-7

SNAP-8

SNAP-8 (Acetyl Octapeptide-3) research compound — an octapeptide studied for expression wrinkle reduction via acetylcholine release modulation. The KLOW skin peptide in Clavicular's advanced stack protocol.

CAS: 868844-74-0

Epithalon 50mg

Epithalon tetrapeptide 50mg research compound. Studied for telomerase activation, pineal gland support, and longevity signaling in preclinical models. The anti-aging peptide from Khavinson's research program.

CAS: 307297-39-8

IGF-1 LR3 1mg

IGF-1 LR3 1mg research compound — a long-acting analog of IGF-1 with extended half-life studied for muscle hypertrophy, cell proliferation, and anabolic signaling in preclinical models.

CAS: 946870-92-4